BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19133174)

  • 21. Economic evaluation of universal prenatal HIV screening compared with current 'at risk' policy in a very low prevalence country.
    Chowers M; Shavit O
    Sex Transm Infect; 2017 Mar; 93(2):112-117. PubMed ID: 28213577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
    Avram CM; Greiner KS; Tilden E; Caughey AB
    Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative analysis of costs of single and dual rapid HIV and syphilis diagnostics: results from a randomised controlled trial in Colombia.
    Obure CD; Gaitan-Duarte H; Losada Saenz R; Gonzalez L; Angel-Muller E; Laverty M; Perez F
    Sex Transm Infect; 2017 Nov; 93(7):482-486. PubMed ID: 28495681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unsuccessful voluntary prenatal testing for human immunodeficiency virus infection.
    Schoen EJ; Limata C; Black SB
    Pediatr Infect Dis J; 2001 Jan; 20(1):79-81. PubMed ID: 11176574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing PMTCT efforts by repeat HIV testing during antenatal and perinatal care in resource-limited settings: A longitudinal assessment of HIV seroconversion.
    Mushamiri I; Adudans M; Apat D; Ben Amor Y
    PLoS One; 2020; 15(5):e0233396. PubMed ID: 32470004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction.
    Haberland CA; Benitz WE; Sanders GD; Pietzsch JB; Yamada S; Nguyen L; Garber AM
    Pediatrics; 2002 Sep; 110(3):471-80. PubMed ID: 12205247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal HIV testing. Time for a change in practice.
    Grant J; Roth C
    Pract Midwife; 1998 Jun; 1(6):16-9. PubMed ID: 9735817
    [No Abstract]   [Full Text] [Related]  

  • 30. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
    Bramley D; Graves N; Walker D
    AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279876
    [No Abstract]   [Full Text] [Related]  

  • 34. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.
    Kim LH; Cohan DL; Sparks TN; Pilliod RA; Arinaitwe E; Caughey AB
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):195-200. PubMed ID: 23392461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.
    Samson L; King S
    CMAJ; 1998 Jun; 158(11):1449-57. PubMed ID: 9629106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed opportunities for congenital syphilis and HIV perinatal transmission prevention.
    Rodrigues CS; Guimarães MD; César CC
    Rev Saude Publica; 2008 Oct; 42(5):851-8. PubMed ID: 18833384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
    Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
    J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study.
    Rodriguez PJ; Roberts DA; Meisner J; Sharma M; Owiredu MN; Gomez B; Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Barr-Dichiara M; Jamil MS; Baggaley R; Johnson C; Taylor MM; Drake AL
    Lancet Glob Health; 2021 Jan; 9(1):e61-e71. PubMed ID: 33227254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV voluntary counseling and testing of couples during maternal labor and delivery: the TRIPAI Couples study.
    Melo M; Varella I; Castro A; Nielsen-Saines K; Lira R; Simon M; Yeganeh N; Rocha T; Bogo Chies JA; Santos B
    Sex Transm Dis; 2013 Sep; 40(9):704-9. PubMed ID: 23949585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.